GURUFOCUS.COM » STOCK LIST » Technology » Software » IBEX Ltd (NAS:IBEX) » Definitions » Sloan Ratio %

IBEX (IBEX) Sloan Ratio % : 0.95% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is IBEX Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

IBEX's Sloan Ratio for the quarter that ended in Mar. 2024 was 0.95%.

As of Mar. 2024, IBEX has a Sloan Ratio of 0.95%, indicating the company is in the safe zone and there is no funny business with accruals.


IBEX Sloan Ratio % Historical Data

The historical data trend for IBEX's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IBEX Sloan Ratio % Chart

IBEX Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only 9.48 -20.03 6.50 2.50 2.99

IBEX Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.60 -0.67 -0.05 0.95

Competitive Comparison of IBEX's Sloan Ratio %

For the Information Technology Services subindustry, IBEX's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IBEX's Sloan Ratio % Distribution in the Software Industry

For the Software industry and Technology sector, IBEX's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where IBEX's Sloan Ratio % falls into.



IBEX Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

IBEX's Sloan Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Sloan Ratio=(Net Income (A: Jun. 2023 )-Cash Flow from Operations (A: Jun. 2023 )
-Cash Flow from Investing (A: Jun. 2023 ))/Total Assets (A: Jun. 2023 )
=(31.582-41.859
--19.037)/293.324
=2.99%

IBEX's Sloan Ratio for the quarter that ended in Mar. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Mar. 2024 )
=(28.32-35.913
--10.356)/289.585
=0.95%

IBEX's Net Income for the trailing twelve months (TTM) ended in Mar. 2024 was 4.51 (Jun. 2023 ) + 7.425 (Sep. 2023 ) + 6.075 (Dec. 2023 ) + 10.31 (Mar. 2024 ) = $28.3 Mil.
IBEX's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2024 was 17.435 (Jun. 2023 ) + 8.684 (Sep. 2023 ) + -1.637 (Dec. 2023 ) + 11.431 (Mar. 2024 ) = $35.9 Mil.
IBEX's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2024 was -3.721 (Jun. 2023 ) + -2.052 (Sep. 2023 ) + -2.892 (Dec. 2023 ) + -1.691 (Mar. 2024 ) = $-10.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IBEX  (NAS:IBEX) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Mar. 2024, IBEX has a Sloan Ratio of 0.95%, indicating the company is in the safe zone and there is no funny business with accruals.


IBEX Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of IBEX's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


IBEX (IBEX) Business Description

Traded in Other Exchanges
Address
Crawford House, 50 Cedar Avenue, Hamilton, BMU, HM 11
IBEX Ltd is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.
Executives
Taylor C Greenwald officer: Chief Financial Officer C/O SYNCHRONOSS TECHNOLOGIES, INC., 200 CROSSING BOULEVARD, 3RD FLOOR, BRIDGEWATER NJ 08807
Michael Joseph Darwal officer: Interim CFO and EVP, IR 1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON DC 20006
Resource Group International Ltd director, 10 percent owner CRAWFORD HOUSE,, 50 CEDAR AVENUE, HAMILTON D0 HM 11
Pinebridge Global Emerging Markets Partners Ii, L.p. director, 10 percent owner 65 EAST 55TH STREET, NEW YORK NY 10022
Robert Thomas Dechant director, officer: Chief Executive Officer 350 CAMPUS DRIVE, MARLBOROUGH MA 01752
Kevin Clowe 10 percent owner C/O PINEBRIDGE GEM II G.P., L.P., 65 EAST 55TH STREET, NEW YORK NY 10022
Pierre Mellinger 10 percent owner C/O PINEBRIDGE GEM II G.P., L.P., 65 EAST 55TH STREET, NEW YORK NY 10022
Mohammedulla Khaishgi director 1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON DC 20006
John Leone director, 10 percent owner 1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON DC 20006
James Dominic Ferrato officer: Chief Information Officer 1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON DC 20006
Paul Joseph Inson officer: Chief People Officer 1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON DC 20006
David Martin Afdahl officer: Chief Operating Officer 1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON DC 20006
Julie K Casteel officer: Chief Sales/Marketing Officer 1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON DC 20006
Jeffrey Hays Cox officer: President of IBEX Digital 1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON DC 20006
Bruce Neil Dawson officer: Chief Sales and CS Officer 1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON DC 20006